FULC R&D to Revenue
Fulcrum Therapeutics Inc · R&D to Revenue
FULC R&D to Revenue
Latest reported0.00%period ending
FULC Quarterly R&D/Revenue (0.00% → 0.00%)
Latest values, visible window
High-resolution chart · PNG
FULC r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 21.5762% | |
| 0% | |
| 2,181.2859% | |
| 2,402.8986% | |
| 2,028.2955% | |
| 5,666.1017% | |
| 2,710.365% | |
| 1,298.9011% | |
| 1,329.3836% | |
| 687.9244% | |
| 373.9027% | |
| 346.0385% | |
| 396.6674% | |
| 341.0733% | |
| 382.1302% | |
| 846.3203% | |
| 638.75% | |
| 1,930.9333% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |